Dextran

• UNSPSC Description:

  Dextran (Dextran 40) has an inhibitory effect on thrombocyte aggregation and coagulation factors and is used as a plasma volume expander.

• Target Antigen:

  Bacterial

• Type:

  Oligonucleotides

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cardiovascular Disease; Cancer

• Assay Protocol:

  https://www.medchemexpress.com/dextran.html

• Purity:

  95.0

• Solubility:

  H2O : 100 mg/mL (ultrasonic)

• Smiles:

  [Dextran]

• Molecular Weight:

  40000.00

• References & Citations:

  [1]Bark BP, et al. Infusion rate and plasma volume expansion of dextran and albumin in the septic guinea pig. Acta Anaesthesiol Scand. 2014 Jan;58(1):44-51.|[2]Santos ES, et al. Anti-inflammatory activity of herb products from Licania rigida Benth. Complement Ther Med. 2019 Aug;45:254-261.|[3]REDEI A. Investigations on the mechanism of dextran induced oedema in rats. Med Exp Int J Exp Med. 1962;6:73-8. |[4]GOEZSY B, et al. INVESTIGATIONS INTO THE MECHANISM OF DEXTRANINDUCED EDEMA IN RATS. Can J Biochem Physiol. 1963 Sep;41:1855-63.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  Launched

• CAS Number:

  9004-54-0